Exenatide Lowered Fasting Plasma Glucose

-20

-10

0

10

20

–12 mg/dL

*

–10 mg/dL

*

+11 mg/dL

Change in FPG From Baseline (mg/dL)

Placebo (n=483)

5 µg (N=480)

10 µg (N=483)

Reductions at 30 Weeks, Combined Pivotals (ITT), Baseline = 179 mg/dL* Statistically different from placebo

Previous slide

Next slide

Back to first slide

View graphic version